Sector Chart Myriad Genetics, Inc.

Stocks

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 00:00:00 24/07/2026 +04			5-day change	1st Jan Change
5.700 ^USD	+0.71%		-7.92%	-7.32%

07-20	Burning Rock Biotech Limited and Myriad Genetics Announce Global Strategic Technology Licensing Partnership to Expand Hrd Testing Worldwide	CI
07-02	Myriad Genetics Publishes Large-Scale Meta-Analysis Demonstrating Prognostic Performance of Prolaris Biopsy Test in Localized Prostate Cancer	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Diagnostic & Testing Substances

	Capi.	Finances	EV / Sales	P/E
MYRIAD GENETICS, INC.	535M	-	-	-
GUARDANT HEALTH, INC.	19.99B			-
BIOMÉRIEUX	9.4B
LANTHEUS HOLDINGS, INC.	6.81B
10X GENOMICS, INC.	5.97B			-
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	5.62B